"Today's decision by the FDA reflects the continued progress in how we understand and treat patients with MASH, bringing us closer to care that meets the needs of people living with this disease." - Arun Sanyal, MD, director, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University Nearly 1 in 20 US individuals are living with MASHa severe form of fatty liver disease that can cause life-threatening outcomes if not treated properlyand around 1 in 3 individuals who are living with overweight or obesity also have MASH
CBD gummies are different from THC gummies because CBD is not intoxicating in the same way THC is
As it turns out, only one in eight, or roughly 12 percent of the U.S
Drinking water throughout the day helps control appetite and supports metabolism
Most people stabilize as they reach the therapeutic doses (5 mg and above), although experiences vary
Every GLP-1 medication has slightly different side effects, so if you know which one youre going to be starting, its a good idea to take a look at the side effects for that specific drug so you know what to be aware of
